Novel compound for treatment of severe hypoglycemiaThe present invention provides a novel compound useful in the treatment of hypoglycemia.J.阿尔西纳-费尔南德斯R.C.卡明斯郭莉莉
The fear of hypoglycemia has a significant effect on the quality of life of patients and their families. In the acute setting, hypoglycemia can kill, and clinical trials have demonstrated that a single episode of severe hypoglycemia increases the risk of subsequent mortality and cardiovascular events...
Severe hypoglycemia occurred only among patients in the intensive treatment group (15/581 [2.6%]; risk difference, 2.58% [95% CI, 1.29% to 3.87%]). Conclusions and Relevance Among patients with acute ischemic stroke and hyperglycemia, treatment with intensive vs standard glucose control for up ...
Objective: To review dasiglucagon, a novel glucagon analogue approved by the Food and Drug Administration (FDA) for treatment of severe hypoglycemia in 202... AL Goodhart - 《Annals of Pharmacotherapy》 被引量: 0发表: 2023年 Evaluating Ease of Use and Patient Safety of Dasiglucagon Hypo Pal...
In cases of severe hypoglycemia, you may require an injection ofbaqsimi,dasiglucagon(Zegalogue), or glucagon injection (Gvoke). Your doctor may find that you take too much insulin that peaks toward the evening-to-morning hours. In that case, they may lower your insulin dose or change the ...
Family members or friends of a person with diabetes should learn how to bring a patient out of severe hypoglycemia by giving the person orange juice or another carbohydrate, or by giving an injection of the drug glucagon, which can raise blood sugar....
Severe hypoglycemia is when blood sugar goes below 54 mg/dL. This can make you faint. When your blood sugar is this low, you might need someone else to give you emergency treatment such asglucagon. Hypoglycemia Causes When you think of sugar, you might think of the sweet stuff in desserts...
OBJECTIVESevere hypoglycemia is a feared complication of type 1 diabetes; yet, few trials have targeted prevention using optimized self-management (educational, therapeutic, and technological support). We aimed to investigate whether imp... SA Little,J Speight,L Leelarathna,... - 《Diabetes Care》...
BACKGROUND: Prolonged severe hypoglycemia (SH) in hospitalized patients is associated with increased morbidity and mortality. This study was undertaken to identify risk factors for SH, to apply that knowledge to the development of a prediction algorithm, and to institute a prevention program at a te...
Reduced Severe Hypoglycemia with Insulin Glargine in Intensively Treated Adults with Type 1 Diabetes OBJECTIVE: The purpose of this study was to compare the effect of insulin glargine (glargine) and NPH insulin (NPH) on long-term outcomes in type 2 diabete... Garg,K S.,Paul,... - 《Diabet...